Page 2 - Quidel Sofia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lab reports 1st instance of SARS-CoV-2 variants affecting antigen test performance The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has entered the second year and is marked by the emergence of several new and more infectious variant lineages. Many of these variants are also associated with immune escape. The mutations in these variants are usually in the spike protein, which evolves rapidly in coronaviruses because of the continual need to escape humoral immunity. The evolution of the virus has affected many aspects of the COVID-19 pandemic, including mortality, ther...

After screening more than 1,100 independently assessed, point-of-care COVID-19 tests, researchers at NSF International and Novateur Ventures have identified 5 direct (antigen/RNA) tests for detection of acute infection and 6 indirect (antibody) tests for detection of prior infection that meet the recently published World Health Organization (WHO) “desirable” Target Product Profile (TPP) criteria. The researchers hope their work will help communities and healthcare systems make more informed decisions when choosing rapid, point-of-care COVID-19 tests. Image by Gerd Altmann from Pixabay TPP...

Share this article Share this article TACOMA, Wash., Jan. 6, 2021 /PRNewswire/ -- GenCare Lifestyle, which operates six assisted living and retirement communities in the Puget Sound has launched the first-of-its-kind on-site, rapid testing for Covid-19 and flu with the ability to understand initial results within 15-30 minutes. The rapid test program administered by CAIPHI EP Testing mobile testing teams can provide results within minutes at each of GenCare's six assisted living communities. The new rapid tests and the provision of Covid-19 vaccines at the communities in coming weeks are pa...